4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001664281-26-000004
Director sold 155,255 shares at an average $6.95 ($1,078,937)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| PARMAR KUSH Director | 2026-08-06 | Sale | −10,494 | $7.00 | $73,458 | 2,836,098 | I: show line 1 in the form |
| PARMAR KUSH Director | 2026-08-07 | Sale | −52,317 | $6.85 | $358,371 | 2,783,781 | I: show line 2 in the form |
| PARMAR KUSH Director | 2026-08-10 | Sale | −92,444 | $7.00 | $647,108 | 2,691,337 | I: show line 3 in the form |
| Open-market sales · 155,255 sh · avg $6.95 · $1,078,937 | |||||||
Loading xslF345X06/form4-08102026_110836.xml…